The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of low FGFR3 but high CD8 T cell infiltrated immune micro-environment on treatment response with pembrolizumab in upper tract urothelial carcinoma.
 
Keisuke Shigeta
No Relationships to Disclose
 
Kazuhiro Matsumoto
No Relationships to Disclose
 
Yota Yasumizu
No Relationships to Disclose
 
Nobuyuki Tanaka
No Relationships to Disclose
 
Toshikazu Takeda
No Relationships to Disclose
 
Takeo Kosaka
No Relationships to Disclose
 
Shinya Morita
No Relationships to Disclose
 
Ryuichi Mizuno
No Relationships to Disclose
 
Hiroshi Asanuma
No Relationships to Disclose
 
Satoshi Hara
No Relationships to Disclose
 
Mototsugu Oya
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Janssen; MSD; Novartis; Ono Pharmaceutical; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Bayer
Research Funding - Astellas Pharma